Frederick J Meyers

Title(s)Professor, Hematology and Oncology
SchoolUniversity of California, Davis
Address2450 48th Street, ASB Suite 2800, Room 2832
CA 95817
Phone916-734-2412
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Frontiers of University Training to Unlock the Research Enterprise (FUTURE)
    NIH DP7OD018426Sep 20, 2013 - Aug 31, 2018
    Role: Principal Investigator
    K30 Mentored Clinical research Training Program
    NIH/NCRR K30RR022264Sep 19, 2005 - Jun 30, 2010
    Role: Principal Investigator
    Simultaneous Care: Linking Palliation to Clinical Trials
    NIH/NCI R25CA095260Jul 25, 2002 - Jun 30, 2009
    Role: Principal Investigator
    TRAUMA REDUCTION IN END OF LIFE DECISION MAKING
    NIH/NIA R03AG017391Aug 1, 1999 - Jul 31, 2001
    Role: Principal Investigator
    WEST COAST CENTER FOR PALLIATIVE MEDICINE EDUCATION
    NIH/NCI R25CA067068Sep 30, 1994 - Aug 31, 1998
    Role: Principal Investigator
    Southwest Oncology Group/University of California, Davis
    NIH/NCI U10CA046441Jan 1, 1988 - Dec 31, 2015
    Role: Co-Principal Investigator
    NORTHERN CALIFORNIA ONCOLOGY GROUP
    NIH/NCI U10CA025838Aug 1, 1983 - Jul 31, 1987
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prevalence and Clinicopathologic Features of Canine Metastatic Melanoma Involving the Central Nervous System: A Retrospective Analysis and Comparative Review. Front Oncol. 2022; 12:868004. Razmara AM, Wittenburg LA, Al-Nadaf S, Toedebusch RG, Meyers FJ, Toedebusch CM. PMID: 35692802; PMCID: PMC9186031.
      View in: PubMed   Mentions:
    2. Dietary Management of Heart Failure: DASH Diet and Precision Nutrition Perspectives. Nutrients. 2021 Dec 10; 13(12). Wickman BE, Enkhmaa B, Ridberg R, Romero E, Cadeiras M, Meyers F, Steinberg F. PMID: 34959976; PMCID: PMC8708696.
      View in: PubMed   Mentions:
    3. Chemotherapy After Diagnosis of Malignant Bowel Obstruction is Associated with Superior Survival for Medicare Patients with Advanced Malignancy. Ann Surg Oncol. 2021 Nov; 28(12):7555-7563. Bateni SB, Gingrich AA, Kirane AR, Sauder CAM, Gholami S, Bold RJ, Meyers FJ, Canter RJ. PMID: 33829359; PMCID: PMC8519893.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. High Versus Low Volume Fluid Resuscitation Strategies in a Porcine Model (Sus scrofa) of Combined Thermal and Traumatic Brain Injury. Shock. 2021 04 01; 55(4):536-544. Guenther TM, Spruce MW, Bach LM, Caples CM, Beyer CA, Grayson JK, Meyers FJ, Palmieri TL, Brown IE. PMID: 32881757.
      View in: PubMed   Mentions:    Fields:    
    5. Homologous Recombination DNA Repair Gene Aberrations-Are We More Alike Than Different? JAMA Netw Open. 2020 10 01; 3(10):e2021717. Arora M, Meyers FJ. PMID: 33112396.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Building a comprehensive mentoring academy for schools of health. J Clin Transl Sci. 2019 Oct; 3(5):211-217. Schweitzer JB, Rainwater JA, Ton H, Giacinto RE, Sauder CAM, Meyers FJ. PMID: 31660245; PMCID: PMC6813514.
      View in: PubMed   Mentions: 1  
    7. Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management. BMC Cancer. 2018 Nov 26; 18(1):1166. Bateni SB, Gingrich AA, Stewart SL, Meyers FJ, Bold RJ, Canter RJ. PMID: 30477454; PMCID: PMC6258444.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    8. Palliative Care Training and Decision-Making for Patients with Advanced Cancer: A Comparison of Surgeons and Medical Physicians. Surgery. 2018 Apr 27. Bateni SB, Canter RJ, Meyers FJ, Galante JM, Bold RJ. PMID: 29709369; PMCID: PMC6204113.
      View in: PubMed   Mentions: 3     Fields:    
    9. Comparison of common risk stratification indices to predict outcomes among stage IV cancer patients with bowel obstruction undergoing surgery. J Surg Oncol. 2018 Mar; 117(3):479-487. Bateni SB, Bold RJ, Meyers FJ, Canter DJ, Canter RJ. PMID: 29044598; PMCID: PMC5854521.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Lung resection is safe and feasible among stage IV cancer patients: An American College of Surgeons National Surgical Quality Improvement Program analysis. Surgery. 2017 05; 161(5):1307-1314. Bateni SB, David EA, Bold RJ, Cooke DT, Meyers FJ, Canter RJ. PMID: 28011006.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice. PLoS One. 2016; 11(10):e0165315. Bateni SB, Meyers FJ, Bold RJ, Canter RJ. PMID: 27780274; PMCID: PMC5079682.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Editorial--Accelerating precision oncology in the 21st century. Surg Oncol. 2015 Dec; 24(4):359-60. Meyers TJ, Meyers FJ. PMID: 26608412.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiative. FASEB J. 2016 Feb; 30(2):507-14. Meyers FJ, Mathur A, Fuhrmann CN, O'Brien TC, Wefes I, Labosky PA, Duncan DS, August A, Feig A, Gould KL, Friedlander MJ, Schaffer CB, Van Wart A, Chalkley R. PMID: 26432783; PMCID: PMC6188226.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    14. Three Dimensional Culture of Human Renal Cell Carcinoma Organoids. PLoS One. 2015; 10(8):e0136758. Batchelder CA, Martinez ML, Duru N, Meyers FJ, Tarantal AF. PMID: 26317980; PMCID: PMC4552551.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    15. Transforming training to reflect the workforce. Sci Transl Med. 2015 Apr 29; 7(285):285ed4. Mathur A, Meyers FJ, Chalkley R, O'Brien TC, Fuhrmann CN. PMID: 25925677; PMCID: PMC4484856.
      View in: PubMed   Mentions: 10     Fields:    
    16. Current perioperative outcomes for patients with disseminated cancer. J Surg Res. 2015 Jul; 197(1):118-25. Bateni SB, Meyers FJ, Bold RJ, Canter RJ. PMID: 25911950; PMCID: PMC4457583.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. Graduate medical education reform: moving the elephant. J Gen Intern Med. 2014 Nov; 29(11):1434-5. Meyers FJ, Henderson MC. PMID: 24981781; PMCID: PMC4238200.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. A transparent oversight policy for human anatomical specimen management: the University of California, Davis experience. Acad Med. 2014 Mar; 89(3):410-4. Schmitt B, Wacker C, Ikemoto L, Meyers FJ, Pomeroy C. PMID: 24448034.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    19. Training the translational research teams of the future: UC Davis-HHMI Integrating Medicine into Basic Science program. Clin Transl Sci. 2013 Oct; 6(5):339-46. Knowlton AA, Rainwater JA, Chiamvimonvat N, Bonham AC, Robbins JA, Henderson S, Meyers FJ. PMID: 24127920; PMCID: PMC3801412.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. Restructuring academic health centers to advance interdisciplinary collaborations: opportunities for psychiatry departments. Acad Psychiatry. 2013 Mar 01; 37(2):72-5. Meyers FJ, Hales RE, Young HM, Nesbitt TS, Pomeroy C. PMID: 23475231; PMCID: PMC4591057.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Commentary: decentralizing quality improvement. Am J Med Qual. 2013 May-Jun; 28(3):261-2. Shaikh U, Meyers FJ. PMID: 23042916.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Strengthening the career development of clinical translational scientist trainees: a consensus statement of the Clinical Translational Science Award (CTSA) Research Education and Career Development Committees. Clin Transl Sci. 2012 Apr; 5(2):132-7. Meyers FJ, Begg MD, Fleming M, Merchant C. PMID: 22507118; PMCID: PMC3771692.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    23. "Teaching as a Competency": competencies for medical educators. Acad Med. 2011 Oct; 86(10):1211-20. Srinivasan M, Li ST, Meyers FJ, Pratt DD, Collins JB, Braddock C, Skeff KM, West DC, Henderson M, Hales RE, Hilty DM. PMID: 21869655.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    24. Creating the future biomedical research workforce. Sci Transl Med. 2011 Sep 28; 3(102):102fs5. Meyers FJ, Pomeroy C. PMID: 21957169.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg. 2011 Aug; 254(2):333-8. Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, Bold RJ, Canter RJ. PMID: 21677562.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    26. A model for rural oncology. J Oncol Pract. 2011 May; 7(3):168-71. Heifetz LJ, Christensen SD, Devere-White RW, Meyers FJ. PMID: 21886498; PMCID: PMC3092657.
      View in: PubMed   Mentions: 5     Fields:    
    27. Palliative care in urology. Surg Clin North Am. 2011 Apr; 91(2):429-44, x. Wu JN, Meyers FJ, Evans CP. PMID: 21419262.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. J Palliat Med. 2011 Apr; 14(4):465-73. Meyers FJ, Carducci M, Loscalzo MJ, Linder J, Greasby T, Beckett LA. PMID: 21413846; PMCID: PMC3070139.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    29. Recombinant innovation and translational science trainees. Sci Transl Med. 2010 Jul 07; 2(39):39ed5. Meyers FJ. PMID: 20610848.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Radical palliative surgery: new limits to pursue. Pediatr Surg Int. 2009 Oct; 25(10):917-21. Young-Spint M, Guner YS, Meyers FJ, Schneider P, Khatri VP. PMID: 19718542; PMCID: PMC2749181.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Palliative and End-of-Life Care in Correctional Settings. Journal of Social Work in End-of-Life & Palliative Care. 2009 Sep 17; 5(1-2):7-33. Linder LJ, Meyers MF. .
      View in: Publisher Site   Mentions:
    32. Cardiovascular disease in women--challenges deserving a comprehensive translational approach. J Cardiovasc Transl Res. 2009 Sep; 2(3):251-5. Lee JS, Bertakis K, Meyers FJ, Chedin E, Tarantal A, Anderson K, Berglund L. PMID: 19655023; PMCID: PMC2719746.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    33. Probiotics and immunity. J Gastroenterol. 2009; 44(1):26-46. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. PMID: 19159071.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansAnimalsCells
    34. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liver Transpl. 2008 Aug; 14(8):1100-6. Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, Meyers FJ. PMID: 18668666.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    35. Integrating palliative care in severe chronic obstructive lung disease. COPD. 2008 Aug; 5(4):207-20. Hardin KA, Meyers F, Louie S. PMID: 18671146.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    36. Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733. Cancer. 2008 May 15; 112(10):2181-7. Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford ED, Southwest Oncology Group Trial 8733. PMID: 18404692; PMCID: PMC8211356.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Diverse populations can use hospice services appropriately. Am J Med. 2008 Apr; 121(4):e1-2. Meyers FJ, Lin A, Sribney WM, Aguilar-Gaxiola S. PMID: 18374668.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. The immunobiology of mushrooms. Exp Biol Med (Maywood). 2008 Mar; 233(3):259-76. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME. PMID: 18296732.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    39. Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer. 2008 Mar 01; 112(5):1162-8. Martinez SR, Robbins AS, Meyers FJ, Bold RJ, Khatri VP, Goodnight JE. PMID: 18213619.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    40. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun. 2008 May; 30(3):180-96. Deane S, Meyers FJ, Gershwin ME. PMID: 18242059.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    41. Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force. Acad Med. 2007 Dec; 82(12):1211-9. Meyers FJ, Weinberger SE, Fitzgibbons JP, Glassroth J, Duffy FD, Clayton CP, Alliance for Academic Internal Medicine Education Redesign Task Force. PMID: 18046131.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    42. Palliative care for prison inmates: "don't let me die in prison". JAMA. 2007 Aug 22; 298(8):894-901. Linder JF, Meyers FJ. PMID: 17712073.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    43. Can patient coaching reduce racial/ethnic disparities in cancer pain control? Secondary analysis of a randomized controlled trial. Pain Med. 2007 Jan-Feb; 8(1):17-24. Kalauokalani D, Franks P, Oliver JW, Meyers FJ, Kravitz RL. PMID: 17244100.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    44. Redesigning training for internal medicine. Ann Intern Med. 2006 Dec 05; 145(11):865-6; author reply 866. Fitzgibbons JP, Meyers FJ. PMID: 17146075.
      View in: PubMed   Mentions: 2     Fields:    
    45. Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature. J Support Oncol. 2006 Oct; 4(9):460-2, 464; discussion 463-4. Tran QN, Urayama S, Meyers FJ. PMID: 17080734.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    46. Patient desires: a model for assessment of patient preferences for care of severe or terminal illness. Palliat Support Care. 2005 Dec; 3(4):289-99. Knops KM, Srinivasan M, Meyers FJ. PMID: 17039984.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. Confronting the brutal facts in health care. Am J Med. 2005 Oct; 118(10):1061-3. Henderson MC, Meyers FJ, Ibrahim T, Tierney LM. PMID: 16194632.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Medical and surgical palliative care of patients with urological malignancies. J Urol. 2005 Oct; 174(4 Pt 1):1177-82. Ok JH, Meyers FJ, Evans CP. PMID: 16145365.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    49. The Palliative Care in Assisted Living (PCAL) pilot study: successes, shortfalls, and methodological implications. Soc Sci Med. 2006 Jan; 62(1):199-207. Jerant AF, Azari RS, Nesbitt TS, Edwards-Goodbee A, Meyers FJ. PMID: 15987662.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Extending palliative care is there a role for preventive medicine? J Palliat Med. 2005 Jun; 8(3):486-9. Zwerdling T, Hamann K, Meyers F. PMID: 15992188.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. Closing the gap between internal medicine training and practice: Recommendations from recent graduates. Am J Med. 2005 Jun; 118(6):680-5; discussion 685-7. Arora V, Guardiano S, Donaldson D, Storch I, Hemstreet P. PMID: 15922702.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    52. An approach to develop effective health care decision making for women in prison. J Palliat Med. 2005 Apr; 8(2):432-9. Enders SR, Paterniti DA, Meyers FJ. PMID: 15890054.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage. 2004 Dec; 28(6):548-56. Meyers FJ, Linder J, Beckett L, Christensen S, Blais J, Gandara DR. PMID: 15589080.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    54. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. PMID: 15530258.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    55. A strategy for the simultaneous provision of pre-operative palliative care for patients awaiting liver transplantation. Transpl Int. 2004 Sep; 17(8):473-5. Rossaro L, Troppmann C, McVicar JP, Sturges M, Fisher K, Meyers FJ. PMID: 15322744.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    56. Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial. Cancer. 2004 May 15; 100(10):2125-31. Lara PN, Chee KG, Longmate J, Ruel C, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Twardowski P, Doroshow JH, Gandara DR. PMID: 15139054.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsCTClinical Trials
    57. Laser Treatment of Endobronchial Renal Cell Carcinoma. Journal of Bronchology & Interventional Pulmonology. 2004 Apr 1; 11(2):92-97. Chan CA, Juarez JM, Albertson AT, Morrissey MB, Allen AR, Meyers MF. .
      View in: Publisher Site   Mentions:
    58. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139. Cancer. 2004 Feb 15; 100(4):818-25. Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K. PMID: 14770440.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    59. Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma. Cancer. 2004 Jan 01; 100(1):82-8. Lara PN, Meyers FJ, Law LY, Dawson NA, Houston J, Lauder I, Edelman MJ. PMID: 14692027.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    60. The TLC model of palliative care in the elderly: preliminary application in the assisted living setting. Ann Fam Med. 2004 Jan-Feb; 2(1):54-60. Jerant AF, Azari RS, Nesbitt TS, Meyers FJ. PMID: 15053284; PMCID: PMC1466621.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. Centers, institutes, and the future of clinical departments: Part II. Am J Med. 2003 Dec 15; 115(9):745-7. Crist TB, LaRusso NF, Meyers FJ, Clayton CP, Ibrahim T, Association of Professors of Medicine. PMID: 14693335.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition. Clin Cancer Res. 2003 Oct 15; 9(13):4772-81. Lara PN, Quinn DI, Margolin K, Meyers FJ, Longmate J, Frankel P, Mack PC, Turrell C, Valk P, Rao J, Buckley P, Wun T, Gosselin R, Galvin I, Gumerlock PH, Lenz HJ, Doroshow JH, Gandara DR, California Cancer Consortium. PMID: 14581348.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    63. Centers, Institutes, and the future of clinical departments: part I. Am J Med. 2003 Sep; 115(4):337-41. Ibrahim T, O'Connell JB, LaRusso NF, Meyers FJ, Crist TB. PMID: 14509279.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Population-based maximum tolerated dose of irinotecan and carboplatin. Oncology (Williston Park). 2003 Jul; 17(7 Suppl 7):11-6. Wild CA, Wang SE, Gandara DR, Lara PN, Meyers FJ, Tanaka M, Houston J, Lauder J, Lau DH. PMID: 12886868.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    65. Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev. 2003 Jun; 29(3):171-87. Martel CL, Gumerlock PH, Meyers FJ, Lara PN. PMID: 12787712.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    66. Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol. 2003 Apr 01; 21(7):1412-5. Meyers FJ, Linder J. PMID: 12663735.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    67. Prison hospice and pastoral care services in California. J Palliat Med. 2002 Dec; 5(6):903-8. Linder JF, Knauf K, Enders SR, Meyers FJ. PMID: 12685537.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    68. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? Cancer. 2002 Sep 01; 95(5):1009-15. Gandour-Edwards R, Lara PN, Folkins AK, LaSalle JM, Beckett L, Li Y, Meyers FJ, DeVere-White R. PMID: 12209684.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    69. Hospice care for the incarcerated in the United States: an introduction. J Palliat Med. 2002 Aug; 5(4):549-52. Linder JF, Enders SR, Craig E, Richardson J, Meyers FJ. PMID: 12243679.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    70. HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial. Cancer. 2002 May 15; 94(10):2584-9. Lara PN, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Kauderer C, Tichauer G, Twardowski P, Doroshow JH, Gandara DR. PMID: 12173324.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    71. Surgery for emphysema. N Engl J Med. 2002 Mar 14; 346(11):860-2. Meyers FJ. PMID: 11898808.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6. Prostate. 2002 Jan 01; 50(1):27-37. O'Donnell RT, DeNardo SJ, Miers LA, Lamborn KR, Kukis DL, DeNardo GL, Meyers FJ. PMID: 11757033.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    73. Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer. Clin Cancer Res. 2001 Jun; 7(6):1561-8. O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ. PMID: 11410491.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCTClinical Trials
    74. Individualized patient education and coaching to improve pain control among cancer outpatients. J Clin Oncol. 2001 Apr 15; 19(8):2206-12. Oliver JW, Kravitz RL, Kaplan SH, Meyers FJ. PMID: 11304773.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    75. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001 Mar 15; 19(6):1728-33. Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. PMID: 11251003.
      View in: PubMed   Mentions: 192     Fields:    Translation:Humans
    76. Correspondence re: G. C. de Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000. Clin Cancer Res. 2000 Oct; 6(10):4167. Meyers FJ, O' Donnell RT. PMID: 11051273.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice. Prostate. 2000 Aug 01; 44(3):187-92. O'Donnell RT, DeNardo SJ, DeNardo GL, Miers L, Lamborn KR, Kukis DL, Meyers FJ. PMID: 10906734.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    78. Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation. Urology. 2000 Apr; 55(4):521-5. Edelman MJ, Meyers FJ, Miller TR, Williams SG, Gandour-Edwards R, deVere White RW. PMID: 10736495.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    79. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. J Clin Oncol. 2000 Apr; 18(7):1440-50. Small EJ, Meyer M, Marshall ME, Reyno LM, Meyers FJ, Natale RB, Lenehan PF, Chen L, Slichenmyer WJ, Eisenberger M. PMID: 10735891.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    80. Molecular biology of prostate carcinogenesis. Crit Rev Oncol Hematol. 1999 Dec; 32(3):197-208. Lara PN, Kung HJ, Gumerlock PH, Meyers FJ. PMID: 10633849.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    81. Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome. Cancer. 1999 Aug 15; 86(4):684-8. Edelman MJ, Gandara DR, Meyers FJ, Ishii R, O'Mahony M, Uhrich M, Lauder I, Houston J, Gietzen DW. PMID: 10440697.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    82. Cellular drug interaction in the fight against multidrug resistant cancer. Crit Care Med. 1999 Feb; 27(2):244-5. Albertson TE, Meyers F. PMID: 10075036.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    83. Palliative education: a didactic and experiential approach to teaching end-of-life care. J Cancer Educ. 1999; 14(3):154-60. Linder JF, Blais J, Enders SR, Melberg SE, Meyers FJ. PMID: 10512332.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    84. Treatment options in androgen-independent prostate cancer. Cancer Invest. 1999; 17(2):137-44. Lara PN, Meyers FJ. PMID: 10071598.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    85. Perspectives on palliative care: a chair of medicine viewpoint. J Palliat Med. 1999; 2(4):371-5. Meyers FJ. PMID: 15859776.
      View in: PubMed   Mentions:    Fields:    
    86. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors. Cancer. 1998 Dec 15; 83(12):2534-9. Meyers FJ, Gumerlock PH, Chi SG, Borchers H, Deitch AD, deVere White RW. PMID: 9874460.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    87. L6 monoclonal antibody binds prostate cancer. Prostate. 1998 Oct 01; 37(2):91-7. O'Donnell RT, DeNardo SJ, Shi XB, Mirick GR, DeNardo GL, Kroger LA, Meyers FJ. PMID: 9759703.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    88. Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study. Breast Cancer Res Treat. 1998 Sep; 51(2):169-81. Geyer CE, Green SJ, Moinpour CM, O'Sullivan J, Goodwin DK, Canfield VA, Meyers FJ, Osborne CK, Martino S. PMID: 9879778.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    89. Prostate carcinoma: clarification through clinical insight and molecular diagnostics. West J Med. 1998 Jun; 168(6):525. Meyers FJ, DeVere White RW. PMID: 9655997; PMCID: PMC1305073.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    90. Follow-up testing after cancer treatment: is it indicated? West J Med. 1998 Jun; 168(6):528-9. Edelman MJ, Siegel D, Meyers F. PMID: 9656000; PMCID: PMC1305076.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate. 1998 Feb 01; 34(2):145-51. Mack PC, Chi SG, Meyers FJ, Stewart SL, deVere White RW, Gumerlock PH. PMID: 9465946.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    92. Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy. Invest New Drugs. 1998; 16(1):69-75. Edelman MJ, Gandara DR, Perez EA, Lau D, Lauder I, Turrell C, Uhrich M, Meyers F. PMID: 9740546.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    93. Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124). Invest New Drugs. 1998-1999; 16(4):347-51. Meyers FJ, Lew D, Lara PN, Williamson S, Marshall E, Balcerzak SP, Rivkin SE, Samlowski W, Crawford ED. PMID: 10426670.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    94. Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer. Invest New Drugs. 1998; 16(2):179-82. Edelman MJ, Meyers FJ, Grennan T, Lauder J, Doroshow J. PMID: 9848583.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    95. Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2. Cancer. 1997 Dec 15; 80(12 Suppl):2576-82. DeNardo GL, Kukis DL, DeNardo SJ, Shen S, Mausner LF, O'Donnell RT, Lamborn KR, Meyers FJ, Srivastava SC, Miers LA. PMID: 9406712.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    96. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Semin Oncol. 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. Edelman MJ, Meyers FJ, Houston J, Lauder I. PMID: 9346226.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    97. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. J Clin Oncol. 1997 May; 15(5):1858-69. Fisher B, Anderson S, Wickerham DL, DeCillis A, Dimitrov N, Mamounas E, Wolmark N, Pugh R, Atkins JN, Meyers FJ, Abramson N, Wolter J, Bornstein RS, Levy L, Romond EH, Caggiano V, Grimaldi M, Jochimsen P, Deckers P. PMID: 9164196.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    98. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med. 1997 May; 12(5):318-31. Edelman MJ, Meyers FJ, Siegel D. PMID: 9159703; PMCID: PMC1497113.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    99. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys. 1997 Apr 01; 38(1):83-94. Gordon W, Siegmund K, Stanisic TH, McKnight B, Harris IT, Carroll PR, Paradelo JC, Meyers FJ, Chapman RA, Meyskens FL. PMID: 9212008.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    100. Giant carcinoid tumor of the lung. Ann Thorac Surg. 1997 Mar; 63(3):851-2. Sheppard BB, Follette DM, Meyers FJ. PMID: 9066421.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    101. Human androgen receptor expression in prostate cancer following androgen ablation. Eur Urol. 1997; 31(1):1-6. de Vere White R, Meyers F, Chi SG, Chamberlain S, Siders D, Lee F, Stewart S, Gumerlock PH. PMID: 9032526.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    102. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas. J Urol. 1996 Jun; 155(6):2080-4. Borchers H, Meyers FJ, Gumerlock PH, Stewart SL, deVere White RW. PMID: 8618340.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    103. Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study. Urology. 1996 May; 47(5):652-7. Einstein AB, Wolf M, Halliday KR, Miller GJ, Hafermann M, Lowe BA, Meyers FJ, Leimert JT, Crawford ED. PMID: 8650861.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    104. Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group Study. Am J Clin Oncol. 1995 Oct; 18(5):400-2. Marshall ME, Wolf MK, Crawford ED, Weiss GR, Ahmann F, Meyers FJ, Blumenstein B, Eisenberger M, Einstein AB. PMID: 7572756.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    105. Screening for cancer. Is it worth it? West J Med. 1995 Aug; 163(2):166-8. Meyers FJ. PMID: 7571573; PMCID: PMC1303022.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    106. Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial. Leukemia. 1995 Jul; 9(7):1126-9. Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, Balcerzak SP, Appelbaum FR. PMID: 7630183.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    107. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol. 1995 Jun; 13(6):1303-11. Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, Meyers FJ, Holcombe RF, Weiss GR, Mangalik A, et al. PMID: 7751875.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    108. Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: a Southwest Oncology Group study. Cancer Biother. 1995; 10(3):205-9. Marshall ME, Wolf M, Crawford ED, Thompson IM, Flanigan R, Balcerzak SP, Meyers FJ. PMID: 8547959.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    109. A phase II trial of concomitant interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in patients with advanced renal cell carcinoma. J Immunother Emphasis Tumor Immunol. 1995 Jan; 17(1):58-61. O'Donnell RT, Dea G, Meyers FJ. PMID: 7728306.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    110. Quantitation of NM23 expression in human prostate tissues. J Urol. 1994 Jul; 152(1):202-7. Fishman JR, Gumerlock PH, Meyers FJ, deVere White RW. PMID: 7515452.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    111. p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst. 1994 Jun 15; 86(12):926-33. Chi SG, deVere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH. PMID: 7515114.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    112. Prostate cancer screening. Ann Intern Med. 1994 Jun 15; 120(12):1052; author reply 1053. Godley PA. PMID: 7514368.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    113. p53 mutations in benign prostatic hyperplasia. J Natl Cancer Inst. 1993 Nov 17; 85(22):1856-8. Meyers FJ, Chi SG, Fishman JR, deVere White RW, Gumerlock PH. PMID: 7693956.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    114. Rapid PCR construction of a gene containing Lym-1 antibody variable regions. PCR Methods Appl. 1993 Aug; 3(1):46-53. Shi XB, Gumerlock PH, Wellman AA, Meares CF, DeNardo GL, Meyers FJ, DeNardo SJ. PMID: 8220184.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    115. Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study. Cancer. 1993 Jun 01; 71(11):3509-13. Livingston RB, Crowley JJ, Thompson T, Williamson SK, Meyers FJ, O'Rourke T, Neefe JR. PMID: 8387881.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study. Invest New Drugs. 1993 May-Aug; 11(2-3):207-9. Marshall ME, Wolf MK, Crawford ED, Taylor S, Blumenstein B, Flanigan R, Meyers FJ, Hynes HE, Barlogie B, Eisenberger M. PMID: 8262733.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    117. Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinoma. Invest New Drugs. 1993 May-Aug; 11(2-3):211-7. Bukowski RM, Young J, Goodman G, Meyers F, Issell BF, Sergi JS, McLain D, Fyfe G, Finke J. PMID: 8262734.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    118. Phase I study of antilipopolysaccharide human monoclonal antibody MAB-T88. Antimicrob Agents Chemother. 1992 Oct; 36(10):2349-51. Daifuku R, Haenftling K, Young J, Groves ES, Turrell C, Meyers FJ. PMID: 1444318; PMCID: PMC245503.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    119. Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group study. J Urol. 1992 Jul; 148(1):52-4. Meyers FJ, Blumenstein B, Crawford ED, Hynes HE, Montie JE, Taylor SA, Grossman HB, Natale RB. PMID: 1613880.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    120. Suppression and transient induction of lymphokines in cancer patients after administration of polyethylene glycolated interleukin-2. Eur J Immunol. 1992 Mar; 22(3):727-33. Shih Y, Konrad MW, Warren MK, Childs A, Paradise C, Meyers FJ, Groves ES. PMID: 1547819.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    121. Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy. J Urol. 1992 Mar; 147(3 Pt 2):947-51. DeVere White RW, Meyers FJ, Soares SE, Miller DG, Soriano TF. PMID: 1371566.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    122. Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev Infect Dis. 1991 Nov-Dec; 13(6):1053-60. Gumerlock PH, Tang YJ, Meyers FJ, Silva J. PMID: 1775837.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    123. Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction. Cancer. 1991 Apr 15; 67(8):2087-95. Meyers FJ, Gumerlock PH, Kawasaki ES, Wang AM, deVere White RW, Erlich HA. PMID: 2004327.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    124. Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res. 1991 Mar 15; 51(6):1632-7. Gumerlock PH, Poonamallee UR, Meyers FJ, deVere White RW. PMID: 1998954.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    125. A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2. Clin Pharmacol Ther. 1991 Mar; 49(3):307-13. Meyers FJ, Paradise C, Scudder SA, Goodman G, Konrad M. PMID: 2007324.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCTClinical Trials
    126. A three-point approach to anemia. Postgrad Med. 1991 Feb 01; 89(2):179-83, 186. Welborn JL, Meyers FJ. PMID: 1990391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    127. Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study. J Immunother (1991). 1991 Feb; 10(1):57-62. Perez EA, Scudder SA, Meyers FA, Tanaka MS, Paradise C, Gandara DR. PMID: 2012799.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    128. An outpatient approach to the delivery of intensive consolidation chemotherapy to adults with acute lymphoblastic leukemia. Oncol Nurs Forum. 1990 Jul-Aug; 17(4):553-8. Palmer P, Meyers FJ. PMID: 2399168.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Prognosis in disseminated prostate cancer as related to tumor ploidy and differentiation. World Journal of Urology. 1990 Mar 1; 8(1):47-50. White WR, Deitch DA, Tesluk TH, Lamborn LK, Meyers MF. .
      View in: Publisher Site   Mentions:
    130. High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group. Cancer Chemother Pharmacol. 1990; 27(3):243-7. Gandara DR, Perez EA, Wold H, Caggiano V, Malec M, Ahn DK, Meyers F, Carlson RW. PMID: 2176134.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    131. ras p21 expression in ovine pulmonary carcinoma. Vet Immunol Immunopathol. 1989 Dec; 23(3-4):279-91. Meyers FJ, Madewell BR, Gumerlock PH, DeMartini JC. PMID: 2697961.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    132. Sequential flow cytometry and single gene analysis by enzymatic amplification and allele specific oligonucleotide hybridization of urothelial cells. J Urol. 1989 Dec; 142(6):1599-601. Meyers FJ, Gumerlock PH, Teplitz RL, Hatcher SL, deVere White RW. PMID: 2585644.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    133. Canine and bovine ras family expression detected and discriminated by use of polymerase chain reaction. Anticancer Res. 1989 Nov-Dec; 9(6):1743-9. Madewell BR, Gumerlock PH, Saunders KA, Meyers FJ, Kraegel SA, Kawasaki ES. PMID: 2483304.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    134. Partial splenic embolization guided by blood flow measurements. Invest Radiol. 1989 Sep; 24(9):678-83. Link DP, Lantz BM, Seibert JA, Meyers FJ. PMID: 2807821.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    135. Intraventricular morphine administered by hospice nurses to a patient with intractable pain. Am J Hosp Care. 1989 Jul-Aug; 6(4):36-9. Carlisle DW, Smith KA, Frank E, Meyers FJ. PMID: 2604982.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    136. RAS enzyme-linked immunoblot assay discriminates p21 species: a technique to dissect gene family expression. Anal Biochem. 1989 Jul; 180(1):158-68. Gumerlock PH, Meyers FJ, Kokoris SP, Wong G, McCormick FP, de Vere White RW. PMID: 2683857.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    137. Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants. Cancer. 1989 Jun 01; 63(11):2177-81. Meyers FJ, Gumerlock PH, Kokoris SP, deVere White RW, McCormick F. PMID: 2655864.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    138. Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen. J Natl Cancer Inst. 1989 May 10; 81(10):790-4. Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J, De Gregorio MW. PMID: 2541260.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    139. Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses. J Clin Oncol. 1989 Feb; 7(2):173-8. Meyers FJ, Welborn J, Lewis JP, Flynn N. PMID: 2644396.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    140. Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acid. Radiat Res. 1989 Feb; 117(2):198-206. Gumerlock PH, Meyers FJ, Foster BA, Kawakami TG, deVere White RW. PMID: 2646654.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    141. Development of monoclonal antibody imaging of metastatic prostatic carcinoma. Prostate. 1989; 14(3):209-20. Meyers FJ, Denardo SJ, Macey D, White RD, Unger M. PMID: 2471962.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    142. Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia. Leukemia. 1988 Nov; 2(11):711-6. Welborn JL, Lewis JP, Meyers FJ. PMID: 3054348.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    143. Improved approach to patients with normocytic anemia. Am Fam Physician. 1988 Aug; 38(2):191-5. Meyers FJ, Welborn JL, Lewis JP. PMID: 3407586.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    144. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Oncogene. 1988 Aug; 3(2):205-13. Cardiff RD, Gumerlock PH, Soong MM, Dandekar S, Barry PA, Young LJ, Meyers FJ. PMID: 2842717.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    145. Human renal clear cell carcinoma: establishment and characterization of a new cell line (G-2101). In Vitro Cell Dev Biol. 1988 May; 24(5):429-34. Gumerlock PH, Edwards BF, Deitch AD, Meyers FJ. PMID: 2453501.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    146. Renal salt wasting and carboplatinum. Ann Intern Med. 1988 Apr; 108(4):640. Welborn J, Meyers FJ, O'Grady LF. PMID: 3279897.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    147. Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study. J Clin Oncol. 1988 Mar; 6(3):476-83. Torti FM, Shortliffe LD, Williams RD, Pitts WC, Kempson RL, Ross JC, Palmer J, Meyers F, Ferrari M, Hannigan J, et al. PMID: 3280742.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    148. Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer. J Surg Oncol. 1988 Mar; 37(3):165-7. Baker WC, Meyers FJ, White RW. PMID: 2451087.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    149. Epithelial membrane antigen expression in benign and malignant squamous epithelium of the head and neck. Otolaryngol Head Neck Surg. 1987 Sep; 97(3):288-93. Fernandez B, Lund J, Meyers F. PMID: 3118310.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    150. Management of chronic pain. Am Fam Physician. 1987 Jul; 36(1):139-46. Meyers FJ, Meyers FH. PMID: 2440292.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    151. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol. 1987 Jun; 5(6):951-5. Venook AP, Tseng A, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD. PMID: 3585449.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    152. Mast cell disease followed by leukemia with clonal evolution. Leuk Res. 1987; 11(9):769-73. Lewis JP, Welborn JL, Meyers FJ, Levy NB, Roschak T. PMID: 3118098.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    153. High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia. Cancer Chemother Pharmacol. 1987; 20(3):265-6. Chan HY, Meyers FJ, Lewis JP. PMID: 3677301.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    154. The integration of cytogenetic analysis into the evaluation of cryptic exudative effusions. Cancer. 1986 Oct 01; 58(7):1479-83. Meyers FJ, Lewis JP, Marianos S. PMID: 3742465.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    155. A focused approach to patients with cancer of unknown primary site. West J Med. 1986 Sep; 145(3):403-4. Meyers FJ, Lewis JP. PMID: 3765625; PMCID: PMC1306966.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    156. Identification of unsuspected thyroid carcinoma using immunoperoxidase for thyroglobulin. Am J Med. 1986 Jul; 81(1):177-9. Meyers FJ, Goodnight JE. PMID: 3524223.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    157. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Cancer Res. 1986 Jul; 46(7):3722-7. Torti FM, Bristow MM, Lum BL, Carter SK, Howes AE, Aston DA, Brown BW, Hannigan JF, Meyers FJ, Mitchell EP, et al. PMID: 3458531.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    158. Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. Cancer Treat Rep. 1986 Jun; 70(6):805-6. Meyers FJ, Cardiff RD, Quadro R, Gribble M, Kohler M, Medrano V, Mitchell EP, Shiffman R, William L. PMID: 2425963.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    159. Tumor biology in explanation of the failure of screening for cancer and in determination of future strategies. Am J Med. 1986 May; 80(5):911-6. Meyers FJ. PMID: 3706378.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    160. The resolution of phenotypic ambiguity in a case of human leukemia using cytogenetics and immunoglobulin gene rearrangement. Am J Clin Pathol. 1986 Mar; 85(3):372-4. Meyers FJ, Miller CH, Lewis JP. PMID: 3019121.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    161. A phase II study of cisplatin and cytosine arabinoside for recurrent squamous cell carcinoma of the head and neck. Am J Clin Oncol. 1986 Feb; 9(1):58-60. Bernstein JI, Jacobs C, Meyers F, Rich-Goffinet L, Tanaka L. PMID: 3953492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    162. The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study. J Urol. 1985 Dec; 134(6):1118-21. Meyers FJ, Palmer JM, Freiha FS, Harker EG, Shortliffe LD, Hannigan J, McWhirter K, Torti FM. PMID: 3903223.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    163. Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol. 1985 Nov; 3(11):1463-70. Harker WG, Meyers FJ, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirter KM, Torti FM. PMID: 4056840.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    164. Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia. Br J Haematol. 1985 Oct; 61(2):261-5. Lewis JP, Meyers FJ, Tanaka L. PMID: 4041369.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    165. Chronic myelogenous leukemia and breaks at 9q34. Cancer Genet Cytogenet. 1985 Aug; 17(4):367-8. Lewis JP, Meyers FJ. PMID: 3860284.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    166. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study. Cancer Treat Rep. 1985 Jan; 69(1):143-4. Meyers FJ, Lewis B, Mitchell E, William L, Hannigan JF, Gribble M, Torti FM. PMID: 3855385.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    167. Phase II trial of 4'-epi-doxorubicin in metastatic melanoma. Cancer Treat Rep. 1984 Dec; 68(12):1509-10. Torti FM, Porzig KJ, Gandara DR, Volberding P, Mitchell E, Meyers FJ, Kohler M, Gribble M. PMID: 6595059.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    168. Hairy cell leukemia has a B-cell genotype. Hematol Oncol. 1984 Apr-Jun; 2(2):145-50. Meyers FJ, Cardiff RD, Taylor CR, Zuniga M, Radich J. PMID: 6430776.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    169. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer. 1983 Nov 01; 52(9):1563-9. Jacobs C, Meyers F, Hendrickson C, Kohler M, Carter S. PMID: 6352004.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    170. Penile cancer chemotherapy. Recent Results Cancer Res. 1983; 85:143-7. Meyers FJ. PMID: 6191370.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    171. Case 42-1981: Hodgkin's disease. N Engl J Med. 1982 May 06; 306(18):1115. Meyers FJ, Lewis JP, Marianos S. PMID: 7070416.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells